2010

London, UK, 21 December 2010 BTG plc (LSE: BGC), the specialty pharmaceuticals company, is pleased to note the announcement by Centocor Ortho Biotech Inc. that it has submitted a New Drug...

London, UK, 29 November 2010 BTG plc (LSE: BGC), the specialty pharmaceuticals company, today announces the appointment of Dr Melanie Lee CBE as a non-executive director of the Board, effective...

London, UK, 04 November 2010 BTG plc (LSE: BGC), the specialty pharmaceuticals company, today announces its interim results for the six months ended 30 September 2010. Click here to download the PDF

London, UK, 25 October 2010 BTG plc (LSE: BGC), the specialty pharmaceuticals company, today announces that AstraZeneca has commenced dosing patients in a global Phase IIb study to compare the...

London, UK, 15 October 2010 BTG plc (LSE: BGC), the specialty pharmaceuticals company, is pleased to note that Genzyme Corporation has reported further data relating to the potential use of the...

London, UK, 16 September 2010 BTG plc (LSE: BGC), the specialty pharmaceuticals company, today announces the start of the first of three US Phase III trials to explore the safety and efficacy of...

London, UK, 10 September 2010 BTG plc (LSE: BGC), the specialty pharmaceuticals company, is pleased to note the announcement by Ortho Biotech Research & Development, a unit of Cougar...

London, UK, 31 August 2010 BTG plc (LSE: BGC), the specialty pharmaceuticals company, today announces that it has signed an agreement with Nycomed US Inc. concerning the accelerated transition to...

London, UK, 01 April 2010 Strong financial performance US commercial operations established BTG plc (LSE: BGC), the specialty pharmaceuticals company, today provides the following update for the...

London, UK, 04 February 2010 - DigiFab™ Approved in Switzerland - BTG plc (LSE: BGC), the specialty pharmaceuticals company, today announces that Swissmedic, the Swiss Agency for Therapeutic...

London, UK, 21 January 2010 BTG plc (LSE: BGC), the specialty pharmaceuticals company, today announces that dosing has commenced in a European multicentre Phase IIa study of Pleneva™ (formerly...

London, UK, 21 January 2010 BTG plc (LSE: BGC), the specialty pharmaceuticals company, today publishes an interim management statement for the period from 1 October 2009 to 20 January 2010....

Top